AMWELL ANNOUNCES RESULTS FOR FIRST QUARTER 2024
May 01 2024 - 3:05PM
Amwell® (NYSE: AMWL) a small-cap, growth healthcare company and a
leading provider of healthcare software as a service, today
announced financial results for the first quarter ended March 31,
2024. Visit Amwell’s investor relations website at
investors.amwell.com to view the first quarter 2024 earnings
report.
The company will host a conference call to discuss its financial
results today at 5 p.m. ET, Wednesday, May 1. The call can be
accessed via a live audio webcast at investors.amwell.com or by
dialing 1-888-510-2008 for U.S. participants or 1-646-960-0306 for
international participants, referencing conference ID #7830032. A
replay of the call will be available via webcast shortly after the
completion of the call, at the same web link.
About Amwell
Amwell is a leading hybrid care enablement platform in the
United States and globally, connecting and enabling providers,
payers, patients, and innovators to deliver greater access to more
affordable, higher quality care. Amwell believes that hybrid care
delivery will transform healthcare. We offer a single,
comprehensive platform to support all digital health needs from
urgent to acute and post-acute care, as well as chronic care
management and healthy living. With nearly two decades of
experience, Amwell powers the digital care of more than 50 health
plans, which collectively represent more than 100 million covered
lives, and many of the nation’s largest health systems. For more
information, please
visit https://business.amwell.com/.
American Well, Amwell, Converge, SilverCloud and Carepoints are
registered trademarks or trademarks of American Well Corporation in
the United States and other countries. All other trademarks used
herein are the property of their respective owners.
Angela Vogen
Amwell
press@amwell.com
Sue Dooley
Amwell
sue.dooley@amwell.com
American Well (NYSE:AMWL)
Historical Stock Chart
From Apr 2024 to May 2024
American Well (NYSE:AMWL)
Historical Stock Chart
From May 2023 to May 2024